Literature DB >> 25662186

A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians.

Yunhua L Muller1, Paolo Piaggi1, Robert L Hanson1, Sayuko Kobes1, Shujera Bhutta1, Maryam Abdussamad1, Tennille Leak-Johnson2, Matthias Kretzler2, Ke Huang1, E Jennifer Weil1, Robert G Nelson1, William C Knowler1, Clifton Bogardus1, Leslie J Baier3.   

Abstract

A prior genome-wide association study (GWAS) in Pima Indians identified a variant within PFKFB2 (rs17258746) associated with body mass index (BMI). PFKFB2 encodes 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase isoform 2, which plays a role in glucose metabolism. To follow-up on the GWAS, tag SNPs across PFKFB2 were genotyped in American Indians (AI) who had longitudinal data on BMI (n = 6839), type 2 diabetes (T2D; n = 7710), diabetic nephropathy (DN; n = 2452), % body fat (n = 555) and insulin secretion (n = 298). Two SNPs were further genotyped in urban AI to assess replication for DN (n = 864). PFKFB2 expression was measured in 201 adipose biopsies using real-time RT-PCR and 61 kidney biopsies using the Affymetrix U133 array. Two SNPs (rs17258746 and rs11120137), which capture the same signal, were associated with maximum BMI in adulthood (β = 1.02 per risk allele, P = 7.3 × 10(-4)), maximum BMI z-score in childhood (β = 0.079, P = 0.03) and % body fat in adulthood (β = 3.4%, P = 3 × 10(-7)). The adiposity-increasing allele correlated with lower PFKFB2 adipose expression (β = 0.81, P = 9.4 × 10(-4)). Lower expression of PFKFB2 further correlated with higher % body fat (r = -0.16, P = 0.02) and BMI (r = -0.17, P = 0.02). This allele was also associated with increased risk for DN in both cohorts of AI [odds ratio = 1.64 (1.32-2.02), P = 5.8 × 10(-6)], and similarly correlated with lower PFKFB2 expression in kidney glomeruli (β = 0.87, P = 0.03). The same allele was also associated with lower insulin secretion assessed by acute insulin response (β = 0.78, P = 0.03) and 30-min plasma insulin concentrations (β = 0.78, P = 1.1 × 10(-4)). Variation in PFKFB2 appears to reduce PFKFB2 expression in adipose and kidney tissues, and thereby increase risk for adiposity and DN. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25662186      PMCID: PMC4416128          DOI: 10.1093/hmg/ddv040

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  An integrative genomics approach to infer causal associations between gene expression and disease.

Authors:  Eric E Schadt; John Lamb; Xia Yang; Jun Zhu; Steve Edwards; Debraj Guhathakurta; Solveig K Sieberts; Stephanie Monks; Marc Reitman; Chunsheng Zhang; Pek Yee Lum; Amy Leonardson; Rolf Thieringer; Joseph M Metzger; Liming Yang; John Castle; Haoyuan Zhu; Shera F Kash; Thomas A Drake; Alan Sachs; Aldons J Lusis
Journal:  Nat Genet       Date:  2005-06-19       Impact factor: 38.330

2.  Energy policy of the kidney: launch of AMPK as a novel therapeutic target.

Authors:  Masaomi Nangaku
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-10

Review 3.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.

Authors:  L Hue; M H Rider
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

4.  Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation.

Authors:  Chaodong Wu; Johnthomas E Kang; Li-Jen Peng; Honggui Li; Salmaan A Khan; Christopher J Hillard; David A Okar; Alex J Lange
Journal:  Cell Metab       Date:  2005-08       Impact factor: 27.287

5.  Lower energy expenditure predicts long-term increases in weight and fat mass.

Authors:  Paolo Piaggi; Marie S Thearle; Clifton Bogardus; Jonathan Krakoff
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

6.  The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake.

Authors:  Nicola Pannacciulli; Arline D Salbe; Emilio Ortega; Colleen A Venti; Clifton Bogardus; Jonathan Krakoff
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

7.  Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes.

Authors:  E Jennifer Weil; Gudeta Fufaa; Lois I Jones; Tracy Lovato; Kevin V Lemley; Robert L Hanson; William C Knowler; Peter H Bennett; Berne Yee; Bryan D Myers; Robert G Nelson
Journal:  Diabetes       Date:  2013-04-01       Impact factor: 9.461

8.  MAP2K3 is associated with body mass index in American Indians and Caucasians and may mediate hypothalamic inflammation.

Authors:  Li Bian; Michael Traurig; Robert L Hanson; Alejandra Marinelarena; Sayuko Kobes; Yunhua L Muller; Alka Malhotra; Ke Huang; Jessica Perez; Alex Gale; William C Knowler; Clifton Bogardus; Leslie J Baier
Journal:  Hum Mol Genet       Date:  2013-07-03       Impact factor: 6.150

9.  Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy.

Authors:  Shu Meguro; Yusuke Kabeya; Karin Tanaka; Toshihide Kawai; Masuomi Tomita; Takeshi Katsuki; Yoichi Oikawa; Yoshihito Atsumi; Akira Shimada; Masami Tanaka; Junichiro Irie; Yoshifumi Saisho; Hiroshi Itoh
Journal:  Int J Endocrinol       Date:  2013-08-26       Impact factor: 3.257

10.  Lower "awake and fed thermogenesis" predicts future weight gain in subjects with abdominal adiposity.

Authors:  Paolo Piaggi; Jonathan Krakoff; Clifton Bogardus; Marie S Thearle
Journal:  Diabetes       Date:  2013-08-23       Impact factor: 9.461

View more
  7 in total

1.  Integrative Biology of Diabetic Kidney Disease.

Authors:  Jennifer L Harder; Jeffrey B Hodgin; Matthias Kretzler
Journal:  Kidney Dis (Basel)       Date:  2015-09-23

2.  An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome.

Authors:  Christopher E Gillies; Rosemary Putler; Rajasree Menon; Edgar Otto; Kalyn Yasutake; Viji Nair; Paul Hoover; David Lieb; Shuqiang Li; Sean Eddy; Damian Fermin; Michelle T McNulty; Nir Hacohen; Krzysztof Kiryluk; Matthias Kretzler; Xiaoquan Wen; Matthew G Sampson
Journal:  Am J Hum Genet       Date:  2018-07-26       Impact factor: 11.025

3.  LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.

Authors:  Qian Cheng; Lin Wang
Journal:  Cell Cycle       Date:  2020-01-08       Impact factor: 4.534

4.  The impact of genetic variants on BMI increase during childhood versus adulthood.

Authors:  M G Hohenadel; L J Baier; P Piaggi; Y L Muller; R L Hanson; J Krakoff; M S Thearle
Journal:  Int J Obes (Lond)       Date:  2016-04-14       Impact factor: 5.551

5.  Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.

Authors:  Nathan Lawlor; Joshy George; Mohan Bolisetty; Romy Kursawe; Lili Sun; V Sivakamasundari; Ina Kycia; Paul Robson; Michael L Stitzel
Journal:  Genome Res       Date:  2016-11-18       Impact factor: 9.043

6.  Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia.

Authors:  R Ellis; M Katerelos; S W Choy; N Cook; M Lee; K Paizis; G Pell; S Walker; D A Power; P F Mount
Journal:  J Transl Med       Date:  2019-02-28       Impact factor: 5.531

7.  Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells.

Authors:  Kenichiro Furuyama; Simona Chera; Léon van Gurp; Daniel Oropeza; Luiza Ghila; Nicolas Damond; Heidrun Vethe; Joao A Paulo; Antoinette M Joosten; Thierry Berney; Domenico Bosco; Craig Dorrell; Markus Grompe; Helge Ræder; Bart O Roep; Fabrizio Thorel; Pedro L Herrera
Journal:  Nature       Date:  2019-02-13       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.